Remarkably, over-expression of ATAD2 was also significantly associated with tumor size, differentiation, and clinical lymph node metastasis stage and could be used as an independent prognostic factor in GC patients 40(Figure 3F). The gene discussed is ATAD2; the disease is neoplasm.